eHealth, Inc.
EHTH- Exchange
- Nasdaq
- Industry
- Insurance Agents, Brokers & Service
- SEC CIK
- 0001333493
In the last 90 days, eHealth, Inc. insiders filed 0 open-market purchases and 2 sales; 78 institutions reported holding it in 13F filings for Q3 2026, worth $9.38M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:46 PM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025! | FY2024! | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 26, 2025 | Jan 26, 2024 | Jan 24, 2023 | Mar 1, 2022 |
| Revenue | $554.0M | $532.4M | $452.9M | $405.4M | $538.2M |
| Cost of revenue | $1.33M | $1.79M | $1.77M | $1.65M | $1.99M |
| Gross profit | $240.8M | $208.5M | – | – | – |
| Research and development | $13.8M | $12.4M | $13.7M | $12.1M | $10.4M |
| Selling, general and administrative | $89.6M | $89.8M | $86.8M | $71.8M | $75.7M |
| Operating income | $66.5M | $23.6M | -$29.1M | -$102.7M | -$125.6M |
| Interest expense | – | – | $11.0M | – | – |
| Income tax | $18.7M | $9.26M | -$2.38M | -$17.7M | -$20.5M |
| Net income | $40.0M | $10.1M | -$28.2M | -$88.7M | -$104.4M |
| EPS, basic | $-0.34 | $-1.19 | $-2.37 | $-4.36 | $-4.59 |
| EPS, diluted | $-0.34 | $-1.19 | $-2.37 | $-4.36 | $-4.59 |
| Weighted shares, basic | 30.5M | 29.3M | 28.0M | 27.4M | 26.8M |
| Weighted shares, diluted | 30.5M | 29.3M | 28.0M | 27.4M | 26.8M |
| Margins and growth | |||||
| Gross margin | 43.5% | 39.2% | – | – | – |
| Operating margin | 12.0% | 4.4% | -6.4% | -25.3% | -23.3% |
| Net margin | 7.2% | 1.9% | -6.2% | -21.9% | -19.4% |
| Revenue growth, year over year | +4.1% | +17.6% | +11.7% | −24.7% | −7.6% |
| Net income growth, year over year | +298.2% | – | – | – | −329.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025! | FY2024! | FY2023! | FY2022! | FY2021! |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 26, 2025 | Jan 26, 2024 | Jan 24, 2023 | Mar 1, 2022 |
| Cash and equivalents | $73.7M | $39.2M | $115.7M | $144.4M | $81.9M |
| Accounts receivable | $7.69M | $16.8M | $3.99M | $2.63M | $5.75M |
| Total current assets | $334.4M | $354.5M | $382.4M | $401.1M | $407.6M |
| Property, plant and equipment | $4.53M | $4.44M | $4.86M | $5.50M | $12.1M |
| Goodwill | – | – | $0 | $0 | $0 |
| Intangible assets | – | – | – | – | $1.92M |
| Total assets | $1.26B | $1.16B | $1.11B | $1.11B | $1.15B |
| Accounts payable | $28.3M | $23.4M | $7.20M | $6.73M | $13.8M |
| Total current liabilities | $99.1M | $96.0M | $78.5M | $60.6M | $75.5M |
| Long-term debt | $113.0M | $68.5M | $67.8M | $66.1M | – |
| Total liabilities | $288.8M | $229.5M | $209.3M | $198.4M | $167.2M |
| Shareholders' equity | $591.6M | $588.4M | $606.0M | $651.0M | $749.5M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 26, 2025 | Jan 26, 2024 | Jan 24, 2023 | Mar 1, 2022 |
| Operating cash flow | -$25.3M | -$18.4M | -$6.69M | -$26.9M | -$162.6M |
| Capital expenditures | $2.25M | $2.09M | $2.09M | $214.0K | $3.87M |
| Free cash flow | -$27.6M | -$20.5M | -$8.78M | -$27.1M | -$166.5M |
| Depreciation and amortization | – | – | $19.9M | $21.1M | $18.3M |
| Stock-based compensation | $15.0M | $19.9M | $23.2M | $20.3M | $32.9M |
| Investing cash flow | $25.4M | -$48.4M | -$15.9M | $25.9M | -$12.6M |
| Financing cash flow | $34.3M | -$9.67M | -$6.22M | $63.8M | $213.2M |
| Net change in cash | $34.5M | -$76.5M | -$28.8M | $62.5M | $38.1M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 2.7% | 3.7% | 5.1% | 5.0% | 6.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.